During the first four years of Horizon 2020 (Work Programmes for 2014/15 and 2016/2017), the EU will invest more than €2 billion in this Challenge; in calls for proposals or actions.
Research & Innovation supported by this call will:
R&I supported by this call will leverage Member State activities in areas including neuroscience, cancer, systems medicine. It will contribute to European and international initiatives such as the European Innovation Partnership on Active and Healthy Ageing, the Global Alliance for Chronic Diseases, the Joint Programming Initiative "More Years, Better Lives - the Challenges and Opportunities of Demographic Change" and the Joint Programming on Neurodegenerative Diseases Research.
Several activities not included in the 2014/15 and 2016/17 work programmes are also part of the 'Health, demographic change and wellbeing' challenge, notably the Innovative Medicines Initiative, the European and Developing Countries Clinical Trials Partnership (EDCTP), and the Active and Assisted Living Programme.
The Scientific Panel for Health is a science-led expert panel, whose role will be to:
This €1 million challenge prize addresses the issue of the unnecessary use of antibiotics, which is contributing to the growing problem of antibiotic resistance. The challenge is to develop a rapid test that will allow healthcare providers to distinguish at the point of care between patients with upper respiratory tract infections that require antibiotics and those that can be treated safely without antibiotics.
Given the increase in food-related health problems, the challenge set for this €1 million prize is to develop an affordable and non-invasive mobile solution that will enable users to measure and analyse their food intake. This solution will especially benefit people with conditions such as obesity, allergies or food intolerance.
This €1 million prize will be split into a maximum of three awards: € 800 000 will go to the winner and € 100 000 each to the first and second runner-ups.
R&I supported by this societal challenge will enable the translation of findings from the laboratory into the clinic and other health and care settings, by engaging all relevant R&I performers. For instance,
A large number of European countries are participating in the Joint Programming Initiative on Antimicrobial Resistance and in the Joint Programming Initiative on Demographic Change.